Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
ZNTL | Zentalis Pharmaceuticals, Inc. | President, Interim CFO, Director | $7.59M | -$262K | -3.33% | May 31, 2024 |
IRD | Opus Genetics, Inc. | Director | $136K | Jun 11, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|